ATE340161T1 - Herstellung von quinapril hydrochlorid - Google Patents

Herstellung von quinapril hydrochlorid

Info

Publication number
ATE340161T1
ATE340161T1 AT04721968T AT04721968T ATE340161T1 AT E340161 T1 ATE340161 T1 AT E340161T1 AT 04721968 T AT04721968 T AT 04721968T AT 04721968 T AT04721968 T AT 04721968T AT E340161 T1 ATE340161 T1 AT E340161T1
Authority
AT
Austria
Prior art keywords
production
quinapril hydrochloride
quinapril
hydrochloride
Prior art date
Application number
AT04721968T
Other languages
English (en)
Inventor
Sandra Marie Jennings
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE340161T1 publication Critical patent/ATE340161T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04721968T 2003-03-31 2004-03-19 Herstellung von quinapril hydrochlorid ATE340161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45901603P 2003-03-31 2003-03-31

Publications (1)

Publication Number Publication Date
ATE340161T1 true ATE340161T1 (de) 2006-10-15

Family

ID=33131855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04721968T ATE340161T1 (de) 2003-03-31 2004-03-19 Herstellung von quinapril hydrochlorid

Country Status (22)

Country Link
US (1) US6858735B2 (de)
EP (1) EP1611106B1 (de)
JP (1) JP2006522092A (de)
KR (1) KR20050115323A (de)
CN (1) CN1747935A (de)
AR (1) AR043949A1 (de)
AT (1) ATE340161T1 (de)
AU (1) AU2004226154B2 (de)
BR (1) BRPI0408924A (de)
CA (1) CA2517451C (de)
CL (1) CL2004000541A1 (de)
DE (1) DE602004002473T2 (de)
DK (1) DK1611106T3 (de)
ES (1) ES2271868T3 (de)
MX (1) MXPA05010498A (de)
PL (1) PL1611106T3 (de)
PT (1) PT1611106E (de)
RS (1) RS20050597A (de)
RU (1) RU2298004C2 (de)
TW (1) TWI284637B (de)
WO (1) WO2004087671A1 (de)
ZA (1) ZA200505214B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053994A1 (en) * 2007-10-26 2009-04-30 Matrix Laboratories Limited Process for preparing pure amorphous quinapril hydrochloride
JP6215339B2 (ja) 2012-11-12 2017-10-18 デピュイ・シンセス・プロダクツ・インコーポレイテッド 椎体間干渉インプラント及び器具

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
EP0065301A1 (de) 1981-05-18 1982-11-24 Merck & Co. Inc. Derivate der Isochinolin-Carbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltendes Arzneimittel
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
ES2122941B1 (es) 1997-05-29 1999-07-01 Esteve Quimica Sa Procedimiento para la obtencion de quinapril clorhidrato y solvatos utiles para el aislamiento y purificacion de quinapril clorhidrato.
WO2002018321A2 (en) * 2000-08-29 2002-03-07 Abbott Laboratories Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
US6541635B1 (en) * 2002-03-29 2003-04-01 Everlight Usa, Inc. Method for producing angiotensin converting enzyme inhibitor
AU2002361494A1 (en) * 2002-12-16 2004-07-09 Lupin Limited Crystalline form of quinapril hydrochloride and process for preparing the same

Also Published As

Publication number Publication date
DK1611106T3 (da) 2006-12-27
AR043949A1 (es) 2005-08-17
ZA200505214B (en) 2008-08-27
KR20050115323A (ko) 2005-12-07
PT1611106E (pt) 2006-11-30
TWI284637B (en) 2007-08-01
JP2006522092A (ja) 2006-09-28
ES2271868T3 (es) 2007-04-16
CN1747935A (zh) 2006-03-15
MXPA05010498A (es) 2005-11-16
AU2004226154A1 (en) 2004-10-14
CA2517451A1 (en) 2004-10-14
CL2004000541A1 (es) 2005-02-04
WO2004087671A1 (en) 2004-10-14
US6858735B2 (en) 2005-02-22
AU2004226154B2 (en) 2007-03-08
PL1611106T3 (pl) 2007-01-31
TW200424177A (en) 2004-11-16
RS20050597A (sr) 2007-09-21
DE602004002473T2 (de) 2007-06-14
EP1611106A1 (de) 2006-01-04
BRPI0408924A (pt) 2006-04-04
DE602004002473D1 (de) 2006-11-02
US20040192613A1 (en) 2004-09-30
CA2517451C (en) 2009-04-21
EP1611106B1 (de) 2006-09-20
RU2298004C2 (ru) 2007-04-27
RU2005130402A (ru) 2006-02-10

Similar Documents

Publication Publication Date Title
DE602004000740D1 (de) Herstellung von Nuten
CY2015015I1 (el) Παραγωγη τιακουμυκινης
DE602004031992D1 (de) Herstellung von elektronischen Geräten
DE112004000372D2 (de) Destillationsverfahren
DE602005011285D1 (de) Formmasse von polymer
ATE450512T1 (de) Enantioselektive herstellung von chinolin- derivaten
DE602004024199D1 (de) Zentralvenenkatheter
DK1692242T3 (da) Viskoelastisk syre
ATE383329T1 (de) Biaryloxymethylarenecarbonsäure
SK4326U (sk) Farmaceutická kompozícia s predĺženým uvoľňovaním
DE602004006228D1 (de) Identifikation alternierender t-wellen
HRP20150163T1 (xx) Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
ATE491814T1 (de) Herstellung von titanoxid
DE602004023786D1 (de) Herstellung von hochreinem Alkylgallium
PL394821A1 (pl) Sposób wytwarzania kombrestatyn
IS8416A (is) Aðferð við framleiðslu á CCR-2 mótlyfi
DE602004021052D1 (de) Herstellungsverfahren von Xylylendiamin
DE602004029836D1 (de) Herstellung von Turbinenelementen
DE60323456D1 (de) Herstellung von Nanopartikeln
DE502004005544D1 (de) Mikrodosiereinrichtung
ATE474824T1 (de) Herstellung von olefinen
DE602004013599D1 (de) Herstellung von somatostatinpeptiden
DE60326321D1 (de) Herstellungsverfahren von Farbstoffen
DE602004002473D1 (de) Herstellung von quinapril hydrochlorid
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1611106

Country of ref document: EP

REN Ceased due to non-payment of the annual fee